KRAS G12C-IN-78
KRAS G12C-IN-78 is a selective SWII-binding KRASG12C dual inhibitor targeting both inactive and active states. KRAS G12C-IN-78 rapidly inhibits ERK1/2 phosphorylation, induces covalent adduct formation with endogenous KRASG12C, suppresses MAPK pathway gene expression, and inhibits cellular proliferation in KRASG12C mutant cells. KRAS G12C-IN-78 can be used for the research of KRASG12C mutant solid tumors, including pancreatic ductal adenocarcinoma and non-small cell lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 3023465-20-2
- Formula: C37H31F4N7O3S
- Molecular Weight:729.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
KRas G12C |
ERK1 |
ERK2 |
KRAS G12C-IN-78 (Compound 6) (2 h) potently inhibits ERK1/2 phosphorylation in MIA PaCa-2 KRASG12C mutant cells with an IC50 of 0.1 nM[1].
KRAS G12C-IN-78 (5 days) potently inhibits proliferation of MIA PaCa-2 KRASG12C mutant cells with an IC50 of 0.1 nM after 5 days of treatment[1].
KRAS G12C-IN-78 shows IC50 values <10 nM for G12C mutant cells and IC50 values >1000 nM for non-G12C mutant cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3023465-20-2
-
Molecular Weight 729.75
-
Formula C37H31F4N7O3S
-
SMILES
[H]C#CC1=C(C=CC2=CC(O)=CC(C3=C(C4=C(C(N5CCN(CC5)C(/C(F)=C/C6=NC=CS6)=O)=NC(OC[C@@]78CCCN7C[C@@H](C8)F)=N4)C=N3)F)=C21)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)